| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Pathogenicity and Medical Microbiology |
Departments of Microbiology and Immunology,1 and Medicine,2 The University of Western Ontario, London, Ontario, CanadaN6A 5C1
Author for correspondence: Miguel A. Valvano. Tel: +1 519 661 3996. Fax: +1 519 661 3499. e-mail: mvalvano{at}julian.uwo.ca
The Burkholderia cepacia complex comprises groups of genomovars (genotypically distinct strains with very similar phenotypes) that have emerged as important opportunistic pathogens in cystic fibrosis (CF) patients. The inflammatory response against bacteria in the airways of CF individuals is dominated by polymorphonuclear cells and involves the generation of oxidative stress, which leads to further inflammation and tissue damage. Bacterial catalase, catalase-peroxidase and superoxide dismutase activities may contribute to the survival of B. cepacia following exposure to reactive oxygen metabolites generated by host cells in response to infection. In the present study the authors investigated the production of catalase, peroxidase and SOD by isolates belonging to various genomovars of the B. cepacia complex. Production of both catalase and SOD was maximal during late stationary phase in almost all isolates examined. Native PAGE identified 13 catalase electrophoretotypes and two SOD electrophoretotypes (corresponding to an Fe-SOD class) in strains belonging to the six genomovars of the B. cepacia complex. Seven out of 11 strains displaying high-level survival after H2O2 treatment in vitro had a bifunctional catalase/peroxidase, and included all the genomovar III strains examined. These isolates represent most of the epidemic isolates that are often associated with the cepacia syndrome. The majority of the isolates from all the genomovars were resistant to extracellular 
, while resistance to intracellularly generated was highly variable and could not be correlated with the detected levels of SOD activity. Altogether the results suggest that resistance to toxic oxygen metabolites from extracellular sources may be a factor involved in the persistence of B. cepacia in the airways of CF individuals.
Keywords: cystic fibrosis, chronic granulomatous disease, oxidative stress, hydrogen peroxide, superoxide anion
Abbreviations: CF, cystic fibrosis; CGD, chronic granulomatous disease; SOD, superoxide dismutase
This article has been cited by other articles:
|
|
 |
|
  S. Yuhara, H. Komatsu, H. Goto, Y. Ohtsubo, Y. Nagata, and M. Tsuda Pleiotropic roles of iron-responsive transcriptional regulator Fur in Burkholderia multivorans Microbiology, June 1, 2008; 154(6): 1763 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Soyza, A. Silipo, R. Lanzetta, J. R. Govan, and A. Molinaro Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides Innate Immunity, June 1, 2008; 14(3): 127 - 144. [Abstract] [PDF]
|
|
|
|
 |
|
 K. E. Keith, L. Killip, P. He, G. R. Moran, and M. A. Valvano Burkholderia cenocepacia C5424 Produces a Pigment with Antioxidant Properties Using a Homogentisate Intermediate J. Bacteriol., December 15, 2007; 189(24): 9057 - 9065. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Keith and M. A. Valvano Characterization of SodC, a Periplasmic Superoxide Dismutase from Burkholderia cenocepacia Infect. Immun., May 1, 2007; 75(5): 2451 - 2460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Lefebre, R. S. Flannagan, and M. A. Valvano A minor catalase/peroxidase from Burkholderia cenocepacia is required for normal aconitase activity Microbiology, June 1, 2005; 151(6): 1975 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Ortega, T. A. Hunt, S. Loutet, A. D. Vinion-Dubiel, A. Datta, B. Choudhury, J. B. Goldberg, R. Carlson, and M. A. Valvano Reconstitution of O-Specific Lipopolysaccharide Expression in Burkholderia cenocepacia Strain J2315, Which Is Associated with Transmissible Infections in Patients with Cystic Fibrosis J. Bacteriol., February 15, 2005; 187(4): 1324 - 1333. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Hunt, C. Kooi, P. A. Sokol, and M. A. Valvano Identification of Burkholderia cenocepacia Genes Required for Bacterial Survival In Vivo Infect. Immun., July 1, 2004; 72(7): 4010 - 4022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Smalley, P. Charalabous, C. A. Hart, and J. Silver Transmissible Burkholderia cepacia genomovar IIIa strains bind and convert monomeric iron(III) protoporphyrin IX into the {micro}-oxo oligomeric form Microbiology, April 1, 2003; 149(4): 843 - 853. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Segal, L. Ding, and S. M. Holland Phagocyte NADPH Oxidase, but Not Inducible Nitric Oxide Synthase, Is Essential for Early Control of Burkholderia cepacia and Chromobacterium violaceum Infection in Mice Infect. Immun., January 1, 2003; 71(1): 205 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Chu, D. J. Davidson, T. K. Halsey, J. W. Chung, and D. P. Speert Differential Persistence among Genomovars of the Burkholderia cepacia Complex in a Murine Model of Pulmonary Infection Infect. Immun., May 1, 2002; 70(5): 2715 - 2720. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
